GHK-Cu is a 503A action (traditional state-licensed compounding for individual prescriptions)
W., Kim, M.-S., Park, J.-Y., Park, K.-G., Lee, H.-J., Lee, I.-K., Lim, S., Jang, H
Studies support sermorelin's role in stimulating GH production through direct pituitary gland interaction, while ibutamoren's ghrelin-mimicking properties provide an alternative mechanism as a ghrelin receptor agonist
Dihexa has gained significant attention in laboratory studies involving learning pathways, synaptogenesis models, neuronal growth factor signaling, memory formation research, and neuroplasticity investigations
Established therapies such as platelet-rich plasma (PRP) have more extensive clinical evidence and regulatory approval for certain applications